Professor John Amory
speaker
76 appearances
1 recordings
1 series
first heard May 2026
last heard 1 May
Professor John Amory’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in May 2026 with 1.
Appearances
Well, certainly it's very acknowledged that the Nestron testosterone transdermal gel is furthest ahead, having completed a phase, what's called 2B study.
I would say that the contraceptives that we do have are all type 1.
They block sperm transmission.
So I'm very interested in these drugs that block ejaculation in men because those would be an easy alternative to a condom, say.
And the medicines that do that are actually already on the market.
So in terms of getting an approval for that, we know these drugs, they've been in the market for 20 years.
They're widely considered to be safe.
These drugs, a lot of them are used actually to treat older men with enlarged prostates to help them urinate.
So we're trying to capitalize on that side effect.
There have been a couple trials.
There was one in Japan and one in India testing this, and some of the men are not enamored of the idea of losing their ejaculation.
I think it's a concept that takes some getting used to.
I just lectured to a bunch of university students, and I asked them to raise their hand if they thought this was a good idea, and none of them did initially.
And then as we discussed it further, some of them thought, well, maybe we'll give it a try.
Yeah, I totally agree.
And one thing that's worth mentioning is there are new methods out there for checking one's sperm count at home.
There are COVID tests that are available to check your sperm count.
I think that it's easier for men to check the status of their contraception much easier than it is for women.
Certainly easily test men at home to see if their contraceptive was functioning.
It's a great question.
Showing 41–60 of 76 · page 3 of 4
← Previous
Next →